Cargando…
Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy
Background: Treatment of breast cancer (BC) includes locoregional and systemic therapies depending on tumor and patient’s characteristics. Inositol hexaphosphate (IP6) is known as a strong antioxidant agent, able to improve local (i.e., breast region) side effects, functional status and quality-of-l...
Autores principales: | Amabile, Maria Ida, De Luca, Alessandro, Tripodi, Domenico, D’Alberti, Elena, Melcarne, Rossella, Imbimbo, Giovanni, Picconi, Orietta, D’Andrea, Vito, Vergine, Massimo, Sorrenti, Salvatore, Molfino, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400775/ https://www.ncbi.nlm.nih.gov/pubmed/34442400 http://dx.doi.org/10.3390/jpm11080756 |
Ejemplares similares
-
Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications
por: Grases, Felix, et al.
Publicado: (2019) -
Application of Inositol Hexaphosphate and Inositol in Dental Medicine: An Overview
por: Druzijanic, Ana, et al.
Publicado: (2023) -
Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: Gavage vs. oral administration with sugar
por: Grases, F., et al.
Publicado: (2019) -
Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice
por: Fu, Min, et al.
Publicado: (2016) -
Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018)